Genotyping Market Size Estimated to be Worth USD 154.35 Billion by 2031, at 22.5% CAGR: The Insight Partners [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
It is estimated to grow at a CAGR of 21.4% from 2022 to 2028. NEW YORK Dec. 10, 2024 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, Global Genotyping Market value is expected to reach US$ 154.35 billion by 2031 from US$ 30.44 billion in 2023 at a CAGR of 22.5%. Genotyping involves determining an individual's genetic makeup by analyzing their DNA sequence. It identifies minor genetic differences that can lead to variations in physical traits and reveal predispositions to certain diseases. By comparing DNA to reference sequences or other individuals, genotyping enhances the understanding of inherited traits. This technique is vital in clinical research, diagnostics, and agriculture, as it is employed in determining the risk of genetic disorders or diagnosing them, developing personalized medicine, and improving crop resilience. The List of Companies - Genotyping Market – F. Hoffmann-La Roche Ltd QIAGEN NV Merck KGaA Eurofins Genomics The
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Colorado's Life Sciences Ecosystem Raised $2.15 Billion in 2024 [Yahoo! Finance]Yahoo! Finance
- QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological DataBusiness Wire
- Qiagen (NYSE: QGEN) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $54.00 price target on the stock, up previously from $42.00.MarketBeat
- QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements [Yahoo! Finance]Yahoo! Finance
- QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 11/6/24 - Beat
QGEN
Sec Filings
- 11/8/24 - Form SC
- 11/8/24 - Form 6-K
- 11/8/24 - Form 6-K
- QGEN's page on the SEC website